Sensei Biotherapeutics
SNSE
SNSE
23 hedge funds and large institutions have $1.31M invested in Sensei Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
46% less capital invested
Capital invested by funds: $2.43M → $1.31M (-$1.12M)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$403K | |
| 2 | +$107K | |
| 3 | +$27.9K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$11.5K |
Top Sellers
| 1 | -$977K | |
| 2 | -$55.7K | |
| 3 | -$34.2K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$21.7K |
| 5 |
Two Sigma Advisers
New York
|
-$19.9K |